Logo image of VIV.PA

VIVENDI SE (VIV.PA) Stock Fundamental Analysis

EPA:VIV - FR0000127771 - Common Stock

3.044 EUR
+0 (+0.13%)
Last: 9/5/2025, 5:35:15 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to VIV. VIV was compared to 42 industry peers in the Entertainment industry. The financial health of VIV is average, but there are quite some concerns on its profitability. VIV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VIV had negative earnings in the past year.
In the past year VIV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: VIV reported negative net income in multiple years.
VIV had a positive operating cash flow in each of the past 5 years.
VIV.PA Yearly Net Income VS EBIT VS OCF VS FCFVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

VIV's Return On Assets of -81.94% is on the low side compared to the rest of the industry. VIV is outperformed by 90.48% of its industry peers.
VIV's Return On Equity of -124.64% is on the low side compared to the rest of the industry. VIV is outperformed by 73.81% of its industry peers.
Industry RankSector Rank
ROA -81.94%
ROE -124.64%
ROIC N/A
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
VIV.PA Yearly ROA, ROE, ROICVIV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

VIV has a Gross Margin of 28.96%. This is amonst the worse of the industry: VIV underperforms 80.95% of its industry peers.
In the last couple of years the Gross Margin of VIV has declined.
The Profit Margin and Operating Margin are not available for VIV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
VIV.PA Yearly Profit, Operating, Gross MarginsVIV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

4

2. Health

2.1 Basic Checks

VIV does not have a ROIC to compare to the WACC, probably because it is not profitable.
VIV has less shares outstanding than it did 1 year ago.
The number of shares outstanding for VIV has been reduced compared to 5 years ago.
Compared to 1 year ago, VIV has a worse debt to assets ratio.
VIV.PA Yearly Shares OutstandingVIV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VIV.PA Yearly Total Debt VS Total AssetsVIV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 1.35, we must say that VIV is in the distress zone and has some risk of bankruptcy.
VIV has a Altman-Z score (1.35) which is comparable to the rest of the industry.
VIV has a debt to FCF ratio of 1.38. This is a very positive value and a sign of high solvency as it would only need 1.38 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.38, VIV belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
VIV has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
VIV has a Debt to Equity ratio (0.39) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 1.38
Altman-Z 1.35
ROIC/WACCN/A
WACC5.79%
VIV.PA Yearly LT Debt VS Equity VS FCFVIV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

VIV has a Current Ratio of 0.51. This is a bad value and indicates that VIV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of VIV (0.51) is worse than 78.57% of its industry peers.
A Quick Ratio of 0.51 indicates that VIV may have some problems paying its short term obligations.
With a Quick ratio value of 0.51, VIV is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
VIV.PA Yearly Current Assets VS Current LiabilitesVIV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

More info and screens

0

3. Growth

3.1 Past

VIV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1628.21%.
VIV shows a decrease in Revenue. In the last year, the revenue decreased by -4.81%.
The Revenue for VIV have been decreasing by -54.89% on average. This is quite bad
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.64%
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-98.4%

3.2 Future

Based on estimates for the next years, VIV will show a small growth in Earnings Per Share. The EPS will grow by 2.57% on average per year.
Based on estimates for the next years, VIV will show a very negative growth in Revenue. The Revenue will decrease by -66.29% on average per year.
EPS Next Y-61.11%
EPS Next 2Y-9.95%
EPS Next 3Y2.57%
EPS Next 5YN/A
Revenue Next Year-96.38%
Revenue Next 2Y-80.65%
Revenue Next 3Y-66.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VIV.PA Yearly Revenue VS EstimatesVIV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
VIV.PA Yearly EPS VS EstimatesVIV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VIV. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 31.76 indicates a quite expensive valuation of VIV.
Based on the Price/Forward Earnings ratio, VIV is valued a bit cheaper than the industry average as 69.05% of the companies are valued more expensively.
VIV is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 31.76
VIV.PA Price Earnings VS Forward Price EarningsVIV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

95.24% of the companies in the same industry are more expensive than VIV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.19
EV/EBITDA N/A
VIV.PA Per share dataVIV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.95%
EPS Next 3Y2.57%

More info and screens

2

5. Dividend

5.1 Amount

VIV has a Yearly Dividend Yield of 1.30%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.05, VIV pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, VIV's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

The dividend of VIV decreases each year by -13.55%.
Dividend Growth(5Y)-13.55%
Div Incr Years0
Div Non Decr Years2
VIV.PA Yearly Dividends per shareVIV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

The earnings of VIV are negative and hence is the payout ratio. VIV will probably not be able to sustain this dividend level.
DP-0.67%
EPS Next 2Y-9.95%
EPS Next 3Y2.57%
VIV.PA Yearly Income VS Free CF VS DividendVIV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

More info and screens

VIVENDI SE

EPA:VIV (9/5/2025, 5:35:15 PM)

3.044

+0 (+0.13%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-20 2025-10-20
Inst Owners25.97%
Inst Owner ChangeN/A
Ins Owners30.04%
Ins Owner ChangeN/A
Market Cap3.14B
Analysts74.67
Price Target3.7 (21.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend0.25
Dividend Growth(5Y)-13.55%
DP-0.67%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20.12%
PT rev (3m)20.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-39.64%
EPS NY rev (3m)-39.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 31.76
P/S 10.56
P/FCF 2.19
P/OCF 2.69
P/B 0.65
P/tB 0.69
EV/EBITDA N/A
EPS(TTM)-5.96
EYN/A
EPS(NY)0.1
Fwd EY3.15%
FCF(TTM)1.39
FCFY45.68%
OCF(TTM)1.13
OCFY37.16%
SpS0.29
BVpS4.68
TBVpS4.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.94%
ROE -124.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.96%
FCFM 482.16%
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 1.38
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 89.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 1.35
F-Score4
WACC5.79%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)44.94%
Cap/Sales(5y)29.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.64%
EPS Next Y-61.11%
EPS Next 2Y-9.95%
EPS Next 3Y2.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-98.4%
Revenue Next Year-96.38%
Revenue Next 2Y-80.65%
Revenue Next 3Y-66.29%
Revenue Next 5YN/A
EBIT growth 1Y-58.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.6%
EBIT Next 3Y31.38%
EBIT Next 5YN/A
FCF growth 1Y1178.57%
FCF growth 3Y16%
FCF growth 5Y16.53%
OCF growth 1Y133%
OCF growth 3Y3.97%
OCF growth 5Y7.73%